Standard

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. / 53 signatories from 20 countries.

In: Lancet Global Health, Vol. 8, Nr. 6, 06.2020, blz. e754-e755.

Onderzoeksoutput: Bijdrage aan tijdschriftCommentaar/debat

Harvard

53 signatories from 20 countries 2020, 'COVID-19 and risks to the supply and quality of tests, drugs, and vaccines', Lancet Global Health, vol. 8, nr. 6, blz. e754-e755. https://doi.org/10.1016/S2214-109X(20)30136-4

APA

53 signatories from 20 countries (2020). COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Global Health, 8(6), e754-e755. https://doi.org/10.1016/S2214-109X(20)30136-4

Vancouver

53 signatories from 20 countries. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Global Health. 2020 jun;8(6):e754-e755. https://doi.org/10.1016/S2214-109X(20)30136-4

Author

53 signatories from 20 countries. / COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. In: Lancet Global Health. 2020 ; Vol. 8, Nr. 6. blz. e754-e755.

BibTeX

@article{343fc6d67ee24e41bb9a3c19869d4113,
title = "COVID-19 and risks to the supply and quality of tests, drugs, and vaccines",
keywords = "Coronavirus Infections/epidemiology, Diagnostic Tests, Routine/standards, Global Health, Humans, Pandemics/prevention & control, Pharmaceutical Preparations/standards, Pneumonia, Viral/epidemiology, Risk, Vaccines/standards",
author = "{53 signatories from 20 countries} and Newton, {Paul N} and Bond, {Katherine C}",
note = "CPDF",
year = "2020",
month = "6",
doi = "10.1016/S2214-109X(20)30136-4",
language = "English",
volume = "8",
pages = "e754--e755",
journal = "Lancet Global Health",
issn = "2214-109X",
publisher = "ELSEVIER SCI LTD",
number = "6",

}

RIS

TY - JOUR

T1 - COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

AU - 53 signatories from 20 countries

AU - Newton, Paul N

AU - Bond, Katherine C

N1 - CPDF

PY - 2020/6

Y1 - 2020/6

KW - Coronavirus Infections/epidemiology

KW - Diagnostic Tests, Routine/standards

KW - Global Health

KW - Humans

KW - Pandemics/prevention & control

KW - Pharmaceutical Preparations/standards

KW - Pneumonia, Viral/epidemiology

KW - Risk

KW - Vaccines/standards

U2 - 10.1016/S2214-109X(20)30136-4

DO - 10.1016/S2214-109X(20)30136-4

M3 - Comment/debate

C2 - 32278364

VL - 8

SP - e754-e755

JO - Lancet Global Health

JF - Lancet Global Health

SN - 2214-109X

IS - 6

ER -

ID: 3315990